OH

Osnat Hakimi

VP Business Development| MedTech T&D Digital Health & AI-driven HealthTech

Tel Aviv-Yafo, Tel Aviv District

Investor

Invests in

Stages:

Seed
Series A

Locations:

Israel

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $2,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Venture formation
Business Development
Technology Transfer
Implantable Medical Devices
Diabetes
Pre-clinical Studies
Team Management
Translational Research
Medical Devices
Biocompatibility
Data Mining
Natural Language Processing (NLP)
Ontologies
Text Mining
Python (Programming Language)
Databases
Healthcare tech
Investments
Medtech
Biopharmaceuticals

Education

Lists including Osnat

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

R-
Ramot - Tel Aviv University's Tech Transfer Company

2025

  • Vice President of Business Development

    2025

KL
KAHR-Medical Ltd.

2024 - 2025

  • Board Observer

    2024 - 2025

aF
aMoon Fund

2021 - 2025

  • Principal

    2024 - 2025

  • Associate

    2021 - 2024

    HealthTech Investor with deep expertise in AI-driven technologies.

SM
Scipher Medicine

2022 - 2025

  • Board Observer

    2022 - 2025

BS
Barcelona Supercomputing Center

2019 - 2021

  • Visiting Researcher

    2019 - 2021

UP
Universitat Politècnica de Catalunya

2018 - 2020

  • Marie Curie Fellow

    2018 - 2020

BT
Beta-o2 Technologies Ltd.

2017 - 2018

  • Head of Biology

    2017 - 2018

Uo
University of Oxford

2009 - 2017

  • Honorary postdoctoral scientist

    2014 - 2017

  • Postdoctoral Scientist

    2009 - 2014

C-
CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

2014 - 2017

  • Post Doctoral Fellow

    2014 - 2017

QM
Queen Mary, University of London

2005 - 2009

  • PhD student

    2005 - 2009